SCHEMBL671194

SCHEMBL671194

O=C(O)N(CCCCO)Cc1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
REN P00797 2/20 0.55
HDAC1 Q13547 3/20 0.53
HDAC6 Q9UBN7 2/20 0.53
HDAC3 O15379 2/20 0.53
HDAC2 Q92769 2/20 0.53
HDAC8 Q9BY41 2/20 0.53
HDAC4 P56524 1/20 0.53
HDAC7 Q8WUI4 1/20 0.53
HDAC9 Q9UKV0 1/20 0.53
HDAC5 Q9UQL6 1/20 0.53
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
LMNA P02545 1/20 0.49
ALDH1A1 P00352 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
TSHR P16473 1/20 0.46
CNR2 P34972 1/20 0.46
LPAR1 Q92633 1/20 0.46
NCOR2 Q9Y618 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16333819 0.98 REN (0.54) RENHDAC1HDAC6HDAC3HDAC2
SCHEMBL13723381 0.98 REN (0.54) RENHDAC1HDAC6HDAC3HDAC2
SCHEMBL4207867 0.94 HDAC1 (0.57) RENHDAC1HDAC6HDAC3HDAC2
SCHEMBL21628078 0.90 REN (0.56) RENHDAC1HDAC3HDAC2HDAC8
SCHEMBL7778139 0.88 FOLH1 (0.54) RENHDAC1HDAC6HDAC3HDAC2
SCHEMBL26985914 0.87 ALOX5 (0.50) HDAC1HDAC6HDAC3HDAC2HDAC8
SCHEMBL26985651 0.87 ALOX5 (0.51) RENHDAC1HDAC6HDAC3HDAC2
SCHEMBL766565 0.86 L3MBTL1 (0.58) RENHDAC1HDAC6HDAC3HDAC2
SCHEMBL26985835 0.86 TDP1 (0.53) RENHDAC1HDAC6HDAC3HDAC2
SCHEMBL8328142 0.84 HDAC1 (0.47) RENHDAC1HDAC6HDAC3HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12600699-B2 Thiosemicarbazates and uses thereof THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH (US) 2026-04-14 US disclosed
US-20230111252-A1 THIOSEMICARBAZATES AND USES THEREOF THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH (US) 2023-04-13 US disclosed
EP-1549309-A4 SOMATOSTATIN ANALOGUE COMPOUNDS CHEMBRIDGE RES LAB INC (US) 2006-05-17 EP disclosed
EP-1549309-A2 SOMATOSTATIN ANALOGUE COMPOUNDS ChemBridge Research Laboratories, Inc. (US) 2005-07-06 EP disclosed
US-6872827-B2 Somatostatin analogue compounds CHEMBRIDGE RESEARCH LABORATORIES, INC. (US) 2005-03-29 US disclosed
US-20040019069-A1 Somatostatin analogue compounds CHEMBRIDGE CORPORATION 2004-01-29 US disclosed
WO-2003090677-A2 SOMATOSTATIN ANALOGUE COMPOUNDS CHEMBRIDGE RESEARCH LAB., LLC (US) 2003-11-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230111252-A1 THIOSEMICARBAZATES AND USES THEREOF TST, ABAT, AADAC REN 1623/4885HDAC1 547/4885HDAC6 291/4885
US-12600699-B2 Thiosemicarbazates and uses thereof MET, THRB, ABAT REN 511/4885HDAC1 1231/4885HDAC6 1070/4885
US-20040019069-A1 Somatostatin analogue compounds SSTR2, SSTR1, SSTR4 REN 59/4885HDAC1 1411/4885HDAC6 1435/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.